Article metrics

Download PDFPDF

Original research
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

 

Online download statistics by month:

Online download statistics by month: July 2020 to September 2020

AbstractFullPdf
Jul 202011821182734
Aug 2020557552334
Sep 2020514514343
Total225322481411